Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Yanagida

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Gynecologic Oncology|December 16, 2020
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancerAikou Okamoto, Eiji Kondo, Toshiaki Nakamura, et al.
Journal of Gynecologic Oncology|September 9, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 studyDaisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, et al.
Plos One|February 7, 2015
Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinomaAikou Okamoto, Jalid Sehouli, Nozomu Yanaihara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2018
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 17, 2018
TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Nature Genetics|April 25, 2017
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypesYi Kan Wang, Ali Bashashati, Michael S Anglesio, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Gynecologic Oncology|December 16, 2020
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancerAikou Okamoto, Eiji Kondo, Toshiaki Nakamura, et al.
Journal of Gynecologic Oncology|September 9, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 studyDaisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, et al.
Plos One|February 7, 2015
Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinomaAikou Okamoto, Jalid Sehouli, Nozomu Yanaihara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2018
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 17, 2018
TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Nature Genetics|April 25, 2017
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypesYi Kan Wang, Ali Bashashati, Michael S Anglesio, et al.
Pageof 3